摘要
ARIs for diabetes: A series of 2-(3-benzyl-2-oxoquinoxalin-1(2H)-yl)acetic acid derivatives were designed and synthesized as inhibitors of aldose reductase (AR), a novel target for the treatment of diabetes complications. Most of the derivatives proved to be potent and selective, with IC50 values in the low nanomolar to micromolar range.
| 源语言 | 英语 |
|---|---|
| 页(从-至) | 1913-1917 |
| 页数 | 5 |
| 期刊 | ChemMedChem |
| 卷 | 8 |
| 期 | 12 |
| DOI | |
| 出版状态 | 已出版 - 12月 2013 |
联合国可持续发展目标
此成果有助于实现下列可持续发展目标:
-
可持续发展目标 3 良好健康与福祉
学术指纹
探究 'Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors' 的科研主题。它们共同构成独一无二的学术指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver